miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer

Oncology Letters

Volumn 4, Issue 3, 2012, Pages 561-565

  Guo, Yan ^a   Liu, Huihui ^b   Zhang, Hui ^a   Shang, Chao ^a   Song, Yongsheng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Bladder transitional cell carcinoma; Forkhead box protein O1; MiR 96

Indexed keywords

MICRO RNA 96; MICRORNA; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; BLADDER CANCER; BLADDER CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 84863862820     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.775     Document Type: Article

References (20)

1. Pollard C, Smith SC and Theodorescu D: Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med 12: e10, 2010.
2. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, SteineckG, Kogevinas M, Real FX and Malats N: Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 25: 285-295, 2007.
3. Hassen W and Droller MJ: Current concepts in assessment and treatment of bladder cancer. Curr Opin Urol 10: 291-299, 2000.
4. Hirata H, Hinoda Y, Ueno K, Shahryari V, Tabatabai ZL and DahiyaR: MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 33: 41-48, 2012.
5. Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, Miao L, Tothova Z, Horner JW, Carrasco DR, Jiang S, Gilliland DG, Chin L, Wong WH, Castrillon DH and DePinho RA: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128: 309-323, 2007.
6. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, FusiL, DinaRE, Brosens JJ, Ghaem-Maghami S and Lam EW: Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70: 367-377, 2010.
7. Guttilla IK and White BA: Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284: 23204-23216, 2009.
8. Kim TH, Jo SW, Lee YS, Kim YJ, Lee SC, Kim WJ and YunSJ: Forkhead box O-class 1 and forkhead box G1 as prognostic markers for bladder cancer. J Korean Med Sci 24: 468-473, 2009.
9. Bansal N, Yendluri V and Wenham RM: The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 16: 8-13, 2009.
10. Goto T, Takano M, Albergaria A, Briese J, Pomeranz KM, ClokeB, Fusi L, Feroze-Zaidi F, Maywald N, Sajin M, et al: Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. Oncogene 27: 9-19, 2008.
11. Fei X, Qi M, Wu B, Song Y, Wang Y and Li T: MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett586: 392-397, 2012.
12. Várallyay E, Burgyán J and Havelda Z: MicroRNA detection by northern blotting using locked nucleic acid probes. Nat Protoc 3: 190-196, 2008.
13. Guo Y, Liu J, Xu Z, Sun K and Fu W: HLA-B gene participates in the NF-kappaB signal pathway partly by regulating S100A8 in the laryngeal carcinoma cell line Hep2. Oncol Rep 19:1453-1459, 2008.
14. Engels BM and Hutvagner G: Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25: 6163-6169, 2006.
15. Stenvang J, Silahtaroglu AN, Lindow M, Elmen J and KauppinenS: The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin Cancer Biol 18: 89-102, 2008.
16. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, PeckD, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, DowningJR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
17. Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L, Jiang Z, ZhangZ, Yang R, Chen J, et al: MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 6: e18286, 2011.
18. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, ZhangX, Song JS and Fisher DE: Chromatin structure analyses identify miRNA promoters. Genes Dev 22: 3172-3183, 2008.
19. Huang H, Regan KM, Wang F, Wang D, Smith DI, van DeursenJM and Tindall DJ: Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci USA 102: 1649-1654, 2005.
20. Hoekstra AV, Ward EC, Hardt JL, Lurain JR, Singh DK, ButtinBM, Schink JC and Kim JJ: Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. Gynecol Oncol 108: 609-618, 2008.